The Bahamas: regenerative-therapy law, the Grand Bahama Port Area and investment zones
Stem-cell, regenerative and gene therapies fall under the Longevity and Regenerative Therapies Act 2024, which works per provider and per therapy; the Grand Bahama Port Area and the investment-zone laws are separate regimes. We found no public register of approved therapies, no fee schedule and no special clinical licence for Freeport. Each line links to its official source.
What this page covers. Rules and their official sources only, not whether a treatment works.
Longevity and Regenerative Therapies Act, No. 51 of 2024
- The Longevity and Regenerative Therapies Act came into force on 1 September 2024. source
- The Act creates the National Longevity and Regenerative Therapy Board. source
- The Board develops and implements compliance monitoring policies. source
- The Board may appoint a Monitoring Body to inspect and report on approved therapy operations. source
- The Board works with ministries to develop financial or tax incentives for the field. source
- The Board encourages medical tourism in longevity and regenerative therapies. source
- The Board may approve eligible foreign practitioners who work with a suitably qualified Bahamian citizen or local resident partner or associate. source
- The Board receives therapy applications and refers them to the Ethics Committee. source
- The Board issues a written authorisation to begin once facility operating requirements have been satisfied. source
- The Act creates the National Longevity and Regenerative Therapy Ethics Review Committee. source
- The Ethics Committee assesses the safety, efficacy and ethics of therapy applications. source
- The Ethics Committee can grant full, conditional provisional or research approval, or decline an application. source
- The Board is required to maintain a registry of all therapies approved under the Act. source
- Regulations are to prescribe the details, content and accessibility of the therapy registry. source
- Therapy approval applications must be accompanied by the prescribed fee. source
- The Minister may make implementing regulations after consulting the Board. source
- Act 51 of 2024 repeals the Stem Cell Research and Therapy Act. source
- Prior approvals under the former Stem Cell Research and Therapy Act are recognised when the application owner remains in good standing. source
- The LARTA public site describes a government regulatory unit and a private agency that manages submissions through its portal. source
- The Hospitals and Health Care Facilities Licensing Board publishes its own facility-licensing fee schedule. source
- The facility licensing board publishes a public register labelled 2026 Licensed Facilities. source
- Published implementing regulations made under section 25 beyond the Appointed Day Notice. (search, checked 17 Nov 2026)
- A published fee schedule for LARTA therapy approvals under sections 12 and 25. (search, checked 17 Nov 2026)
- A public LARTA-specific register of approved therapies or providers with a stable URL and publication date. (search, checked 17 Nov 2026)
Grand Bahama Port Area / Hawksbill Creek Agreement
- The 1955 Hawksbill Creek Act authorised the agreement for a deep-water harbour and industrial area at Hawksbill Creek. source
- The Government and GBPA entered into the original Hawksbill Creek Agreement in August 1955 for 99 years. source
- The 1966 supplement released GBPA from its original obligation to provide medical services. source
- Under the 1966 supplement GBPA undertook to provide a Port Area site for a government medical-services building. source
- The Government filed its statement of claim against GBPA on 6 September 2024. source
- GBPA amended its defence and counterclaim twice in 2025. source
- The tribunal dismissed the Government’s pleaded reimbursement claim under clause 1(5)(d). source
- The tribunal found that the annual payment review mechanism in paragraph 3 of the 1994 Agreement remained available. source
- The tribunal upheld GBPA’s counterclaim over the Government’s continuing failure to promulgate proposed environmental bye-laws. source
- The Government states that the award confirmed its continued legislative and regulatory authority in the Port Area. source
- National laws and the GBPA system of licences, approvals and bye-laws operate concurrently in Freeport’s Port Area. source
- The Government published a Green Paper on a proposed island-wide governance framework on 21 October 2026. source
- Public consultation on the proposed governance framework runs from 1 November 2026 to 30 April 2027. source
- An enacted amendment to the Hawksbill Creek Agreement or transfer of GBPA’s licensing authority in 2024–2026. (search, checked 17 Nov 2026)
- A subsequent public arbitral award resolving the outstanding damages or costs. (search, checked 17 Nov 2026)
Grand Bahama Port Area / clinic licensing
- GBPA issues Port Area business licences. source
- The Hospitals and Health Care Facilities Licensing Board grants health care facility licences under the national Act. source
- A facility providing therapy or research under Act 51 of 2024 must hold a health care facility licence under Chapter 235. source
- The facility licensing board requires longevity and regenerative facilities to obtain LARTA Board approval before applying for a facility licence. source
- Pharmacy businesses must be registered under the national Pharmacy Act. source
- A special Freeport clinical licence or a zone-level authorisation system specific to medical devices or medicines. (search, checked 17 Nov 2026)
Grand Bahama Port Area / tax and customs
- Clause 2(3) of the original Hawksbill Creek Agreement provides duty-free treatment for qualifying supplies for medical services carried out by GBPA in the Port Area. source
- The original Hawksbill Creek Agreement provides a conditional duty-free route for qualifying Port Area business supplies. source
- The Government trade portal describes Freeport’s general customs, excise, export and stamp-tax concessions as running through 2054. source
- The 2016 Port Area Investment Incentives Act provides for qualifying licensees to seek specified tax concessions. source
- The 2016 Port Area Investment Incentives Act caps the date for concessions granted under the Act at 4 May 2036. source
- The 2021 order extended the deadline for applications to the Port Area Investment Board to 4 July 2022. source
- An extension of the 4 July 2022 investment-incentive application deadline. (search, checked 17 Nov 2026)
- A clinic-specific Freeport tax rate or a blanket Freeport customs concession for private clinic medical devices or medicines. (search, checked 17 Nov 2026)
Grand Bahama Port Area / regenerative or longevity clinics
- Okyanos Operating Company Ltd. operated a stem-cell regenerative medicine clinic at First Commercial Centre, The Mall Drive, Freeport. source
- The Tribune reported that the Okyanos centre held a licence from the National Stem Cell Ethics Committee. source
- The Supreme Court found that Okyanos ceased trading after Hurricane Dorian in September 2019 and had not resumed by the hearing. source
- The Supreme Court ordered Okyanos Operating Company Ltd. wound up on 28 May 2020. source
- The public 2026 facility register lists The Medical Pavilion in Grand Bahama under facility licence C-26-324. source
- A currently operating Freeport longevity or regenerative centre with a published LARTA approval or therapy-specific licence. (search, checked 17 Nov 2026)
Family Islands Development Encouragement Act
- The 2023 amendment made Grand Bahama and all other Family Islands and cays eligible geographies for the building-material relief. source
- The building-material customs and excise exemption is 100% for Bahamians or permanent residents and 50% for non-Bahamians granted the exemption. source
- The 2026 amendment extends the statutory building-material exemption through 30 June 2027. source
Bahamas Investment Incentives Act, 1991 / development zones
- The Governor-General may designate development zones by Gazette notice. source
- Approved developers and licensees may operate hospitals and health clinics with ministerial approval. source
- An approved developer’s qualifying supplies for medical services in a designated zone can fall within the duty-free administrative supplies category. source
- The investment statute places Grand Bahama outside the Port Area in Region B. source
- A published health-sector development-zone designation or an official approval identifying a clinic under this mechanism. (search, checked 17 Nov 2026)
Family Islands Economic Enterprise Zones Act, 2003
- The 2003 Act established a mechanism to apply for customs or stamp duty relief on qualifying capital-investment supplies in zones designated by Gazette order. source
The Bahamas Free Trade Zone Act
- A ministerial Gazette notice may designate an area in which a free industrial or commercial zone can be established. source
- A health-care or medical-tourism zone designated under the 1984 Act. (search, checked 17 Nov 2026)
Special Economic Recovery Zone / Ministry of Finance
- The Ministry of Finance accepts applications for geographic import relief for eligible businesses in listed islands. source
National Investment Policy / medical tourism
- The National Investment Policy lists offshore medical centres as a target for overseas investment. source
- The Bahamas High Commission promotes offshore medical centres and medical tourism as investment opportunities. source
- A separately designated medical-tourism or longevity zone under a published Bahamian instrument. (search, checked 17 Nov 2026)
National rules on cell and gene therapy (country guide)
- The Longevity and Regenerative Therapies Act, No. 51 of 2024, covers stem cell, regenerative and gene therapies. It repeals the former Stem Cell Research and Therapy Act, subject to transitional provisions for approvals in good standing. source
- Under the Longevity and Regenerative Therapies Act, the Ethics Committee may grant full, provisional or research approval. The Act requires a separate written commencement notice from the Board before administration or research can start. source
- The Appointed Day Notice, S.I. No. 73 of 2024, specifies 1 September 2024 as the commencement of the Longevity and Regenerative Therapies Act. source